Search terms
Results 1 - 1 of 1 - ordered by :

Abstract Mineralocorticoid receptor antagonists (MRAs) improve survival and reduce morbidity in patients with heart failure, reduced ejection fraction (HFREF), and mild-to-severe symptoms, and in ...

European Heart Journal, Zannad, Faiez, Gattis Stough, Wendy, Rossignol, Patrick, Bauersachs, Johann, McMurray, John J.V., Swedberg, Karl, Struthers, Allan D., Voors, Adriaan A., Ruilope, Luis M., ...

Date : 01/11/2012 Item size : 605295 bytes